Sorafenib for Prophylaxis of Leukemia Relapse in Allogeneic Hematopoietic Stem Cell Transplant Recipients With FLT3-ITD Positive Acute Myeloid Leukemia
Phase of Trial: Phase IV
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Sorafenib (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 11 Jun 2017 Planned number of patients changed from 100 to 196.
- 09 May 2017 Planned number of patients changed from 200 to 100.
- 09 May 2017 Status changed from not yet recruiting to recruiting.